Schedule 13G ownership disclosure

CARDIOME PHARMA CORP

Security class unavailable · CUSIP: 14159U301

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,508,988
Percent of class
11.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001421578-17-000011
Form type
SC 13G/A
Filer
Correvio Pharma Corp.
CIK
CIK 1036141
Filed
Feb 14, 2017
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub